AMCINONIDE
| Title | Journal |
|---|---|
| Identification and characterization of triamcinolone acetonide, a microglial-activation inhibitor. | Immunopharmacology and immunotoxicology 20121201 |
| Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). | PLoS computational biology 20111201 |
| Atopic dermatitis. | Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 20110101 |
| Contact allergy to topical corticosteroids--results from the IVDK and epidemiological risk assessment. | Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20090101 |
| Allergic contact dermatitis to topical drugs--epidemiological risk assessment. | Pharmacoepidemiology and drug safety 20080801 |
| Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate. | Respiratory research 20070101 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| Angioedema and dysphagia caused by contact allergy to inhaled budesonide. | Contact dermatitis 20030801 |
| Selective corticosteroid injection into the extensor pollicis brevis tenosynovium for de Quervain's disease. | Orthopedics 20020101 |
| Exacerbation of allergic contact dermatitis from amcinonide triggered by patch testing. | Contact dermatitis 20011001 |
| Patch testing with serial dilutions of budesonide, its R and S diastereomers, and potentially cross-reacting substances. | American journal of contact dermatitis : official journal of the American Contact Dermatitis Society 20010901 |
| Tixocortol pivalate contact allergy in the GPMT: frequency and cross-reactivity. | Contact dermatitis 20010101 |
| Delayed generalized allergic reactions to corticosteroids. | Dermatology (Basel, Switzerland) 20000101 |
| Studies in patients with corticosteroid contact allergy. Understanding cross-reactivity among different steroids. | Archives of dermatology 19950101 |
| Contact sensitivity and cross-reactivity of budesonide. | Contact dermatitis 19930401 |
| Contact allergies to topical corticosteroids. | Contact dermatitis 19930301 |
| [Contact allergy to topical glucocorticoids]. | Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 19930201 |
| Contact allergies to topical corticosteroids: 10 cases of contact dermatitis. | Contact dermatitis 19910801 |
| Influence of depigmenting chemical agents on hair and skin color in yellow (pheomelanic) and black (eumelanic) mice. | Pigment cell research 19900101 |
| Allergic contact dermatitis from topical corticosteroids. | Contact dermatitis 19890801 |
| Investigations on the development and regression of corticosteroid-induced thinning of the skin in various parts of the human body during and after topical application of amcinonide. | Dermatologica 19890101 |
| Amcinonide vs. betamethasone dipropionate ointments in the treatment of psoriasis. | Cutis 19850501 |
| Allergic contact dermatitis from amcinonide. | Contact dermatitis 19850401 |
| A comparative study of amcinonide and halcinonide in the treatment of eczematous dermatitis. | Cutis 19840801 |
| Allergy to 2 new corticoid molecules. | Contact dermatitis 19840801 |
| Contact sensitivity to topical corticosteroids. | Journal of the American Academy of Dermatology 19840501 |
| Comparison of amcinonide ointment 0.1 percent twice daily and fluocinonide ointment 0.05 percent three times daily in the treatment of psoriasis. | Cutis 19830501 |
| Treatment of psoriasis with amcinonide 0.1 percent and fluocinonide 0.05 percent ointments. A comparative double-blind study. | Cutis 19820601 |
| A controlled comparison of amcinonide cream 0.1 percent and halcinonide cream 0.1 percent in the treatment of eczematous dermatitis. | Cutis 19811001 |
| [Comparative pharmacological activity of triamcinolone acetonide and of a new topical steroid: amcinonide, after percutaneous or oral administration (author's transl)]. | Journal de pharmacologie 19800101 |
| Management of eczematous dermatitis with amcinonide or betamethasone valerate. A double-blind comparative study. | Cutis 19791201 |